Sources | Names Used |
---|---|
GDSC1000 | KIN001-260 |
PharmacoGx | KIN001-260 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | MYB | GDSC1000 | pan-cancer | AAC | 0.079 | 0.08 |
mRNA | EPB41L4B | GDSC1000 | pan-cancer | AAC | -0.072 | 0.08 |
mRNA | C10orf107 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.08 |
mRNA | GOLGA4 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.08 |
mRNA | GSS | GDSC1000 | pan-cancer | AAC | -0.056 | 0.08 |
mRNA | MBD3L5 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.08 |
mRNA | LMO2 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.08 |
mRNA | DES | GDSC1000 | pan-cancer | AAC | 0.053 | 0.08 |
mRNA | CRIP2 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.08 |
mRNA | MARK4 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.08 |